![Intestinal insulin/IGF1 signalling through FoxO1 regulates epithelial integrity and susceptibility to colon cancer | Nature Metabolism Intestinal insulin/IGF1 signalling through FoxO1 regulates epithelial integrity and susceptibility to colon cancer | Nature Metabolism](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42255-019-0037-8/MediaObjects/42255_2019_37_Fig1_HTML.png)
Intestinal insulin/IGF1 signalling through FoxO1 regulates epithelial integrity and susceptibility to colon cancer | Nature Metabolism
Downregulation of neurotrophic factors in the brain of a mouse model of Gaucher disease; implications for neuronal loss in Gauch
![Cells | Free Full-Text | GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches Cells | Free Full-Text | GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches](https://www.mdpi.com/cells/cells-08-00364/article_deploy/html/images/cells-08-00364-g001.png)
Cells | Free Full-Text | GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches
![PDF) Alterations in the properties of the cell membrane due to glycosphingolipid accumulation in a model of Gaucher disease PDF) Alterations in the properties of the cell membrane due to glycosphingolipid accumulation in a model of Gaucher disease](https://i1.rgstatic.net/publication/322336943_Alterations_in_the_properties_of_the_cell_membrane_due_to_glycosphingolipid_accumulation_in_a_model_of_Gaucher_disease/links/5fbb568b458515b797628282/largepreview.png)
PDF) Alterations in the properties of the cell membrane due to glycosphingolipid accumulation in a model of Gaucher disease
![Therapeutic Strategies for Gaucher Disease: Miglustat (NB-DNJ) as a Pharmacological Chaperone for Glucocerebrosidase and the Different Thermostability of Velaglucerase Alfa and Imiglucerase | Molecular Pharmaceutics Therapeutic Strategies for Gaucher Disease: Miglustat (NB-DNJ) as a Pharmacological Chaperone for Glucocerebrosidase and the Different Thermostability of Velaglucerase Alfa and Imiglucerase | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/mp200313e/asset/images/medium/mp-2011-00313e_0006.gif)
Therapeutic Strategies for Gaucher Disease: Miglustat (NB-DNJ) as a Pharmacological Chaperone for Glucocerebrosidase and the Different Thermostability of Velaglucerase Alfa and Imiglucerase | Molecular Pharmaceutics
![Therapeutic Strategies for Gaucher Disease: Miglustat (NB-DNJ) as a Pharmacological Chaperone for Glucocerebrosidase and the Different Thermostability of Velaglucerase Alfa and Imiglucerase | Molecular Pharmaceutics Therapeutic Strategies for Gaucher Disease: Miglustat (NB-DNJ) as a Pharmacological Chaperone for Glucocerebrosidase and the Different Thermostability of Velaglucerase Alfa and Imiglucerase | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/mp200313e/asset/images/large/mp-2011-00313e_0006.jpeg)
Therapeutic Strategies for Gaucher Disease: Miglustat (NB-DNJ) as a Pharmacological Chaperone for Glucocerebrosidase and the Different Thermostability of Velaglucerase Alfa and Imiglucerase | Molecular Pharmaceutics
![Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives](https://www.futuremedicine.com/cms/10.2217/ebo.12.193/asset/images/medium/figure3.gif)
Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives
![Cells | Free Full-Text | Novel Molecular Therapies and Genetic Landscape in Selected Rare Diseases with Hematologic Manifestations: A Review of the Literature Cells | Free Full-Text | Novel Molecular Therapies and Genetic Landscape in Selected Rare Diseases with Hematologic Manifestations: A Review of the Literature](https://pub.mdpi-res.com/cells/cells-12-00449/article_deploy/html/images/cells-12-00449-ag-550.jpg?1675326720)
Cells | Free Full-Text | Novel Molecular Therapies and Genetic Landscape in Selected Rare Diseases with Hematologic Manifestations: A Review of the Literature
Partial Restoration of Mutant Enzyme Homeostasis in Three Distinct Lysosomal Storage Disease Cell Lines by Altering Calcium Homeostasis | PLOS Biology
![The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? - ScienceDirect The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1096719222001524-gr1.jpg)
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? - ScienceDirect
![IJMS | Free Full-Text | Effects of Intermittent Hypoxia on Cytokine Expression Involved in Insulin Resistance IJMS | Free Full-Text | Effects of Intermittent Hypoxia on Cytokine Expression Involved in Insulin Resistance](https://www.mdpi.com/ijms/ijms-22-12898/article_deploy/html/images/ijms-22-12898-g001.png)
IJMS | Free Full-Text | Effects of Intermittent Hypoxia on Cytokine Expression Involved in Insulin Resistance
![Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives](https://www.futuremedicine.com/cms/10.2217/ebo.12.193/asset/images/medium/figure2.gif)
Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives
![Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses - ScienceDirect Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1388198113002461-gr1.jpg)
Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses - ScienceDirect
![IJMS | Free Full-Text | A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments IJMS | Free Full-Text | A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments](https://pub.mdpi-res.com/ijms/ijms-18-00441/article_deploy/html/images/ijms-18-00441-g002b.png?1569223292)
IJMS | Free Full-Text | A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
![IJMS | Free Full-Text | A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments IJMS | Free Full-Text | A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments](https://www.mdpi.com/ijms/ijms-18-00441/article_deploy/html/images/ijms-18-00441-g001.png)
IJMS | Free Full-Text | A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
![Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease | Scientific Reports Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep10903/MediaObjects/41598_2015_Article_BFsrep10903_Fig7_HTML.jpg)
Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease | Scientific Reports
![Biomolecules | Free Full-Text | Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease Biomolecules | Free Full-Text | Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease](https://pub.mdpi-res.com/biomolecules/biomolecules-10-01630/article_deploy/html/images/biomolecules-10-01630-ag.png?1615454206)